Back
Vertex Pharmaceuticals Stock Price Chart
Sponsored
VRTX
Sponsored
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Buy
62
VRTX
Vertex Pharmaceuticals
Last Price:
400.09
Seasonality Move:
10.13%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.
Vertex Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 398.95 | Buy |
20-day SMA: | 398.88 | Buy |
50-day SMA: | 410.19 | Sell |
200-day SMA: | 384.2 | Buy |
8-day EMA: | 398.1 | Buy |
20-day EMA: | 400.53 | Buy |
50-day EMA: | 406.1 | Sell |
200-day EMA: | 386.17 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.52 | Sell |
Relative Strength Index (14 RSI): | 49.75 | Sell |
Chaikin Money Flow: | 355832 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (394.36 - 409.8) | Buy |
Bollinger Bands (100): | (395.67 - 430.15) | Sell |
Vertex Pharmaceuticals Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 402.18 while VRTX 8-day simple moving average is 398.95, which is a Buy signal.
- The stock price of VRTX is 402.18 while Vertex Pharmaceuticals 20-day SMA is 398.88, which makes it a Buy.
- Vertex Pharmaceuticals 50-day simple moving average is 410.19 while VRTX share price is 402.18, making it a Sell technically.
- VRTX stock price is 402.18 and Vertex Pharmaceuticals 200-day simple moving average is 384.20, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $402.18. The Score for VRTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
103.89B
Price in USD:
402.18
Share Volume:
1.04M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
448.40
52-Week Low:
320.01
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 402.18 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 402.18 while VRTX 8-day exponential moving average is 398.10, which is a Buy signal.
- The stock price of VRTX is 402.18 while Vertex Pharmaceuticals 20-day EMA is 400.53, which makes it a Buy.
- Vertex Pharmaceuticals 50-day exponential moving average is 406.10 while VRTX share price is 402.18, making it a Sell technically.
- VRTX stock price is 402.18 and Vertex Pharmaceuticals 200-day simple moving average is 386.17, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.30 per share, an increase this year of $1.62 per share, and an increase next year of $1.37 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is -3.52, suggesting Vertex Pharmaceuticals is a Sell
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 49.75, which suggest Vertex Pharmaceuticals is oversold
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (394.36 - 409.8), which suggest Vertex Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (395.67 - 430.15), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.